{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:05:42Z","timestamp":1793966742721,"version":"4.8.0"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-019-0118-8","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T06:23:20Z","timestamp":1570688600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1660,"title":["Ischaemic stroke"],"prefix":"10.1038","volume":"5","author":[{"given":"Bruce C. V.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre A.","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh B.","family":"Coutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Schwamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"118_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco, R. L. et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44, 2064\u20132089 (2013).","journal-title":"Stroke"},{"key":"118_CR2","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","volume":"379","author":"VL Feigin","year":"2018","unstructured":"Feigin, V. L. et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N. Engl. J. Med. 379, 2429\u20132437 (2018).","journal-title":"N. Engl. J. Med."},{"key":"118_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/01.STR.12.6.723","volume":"12","author":"J Astrup","year":"1981","unstructured":"Astrup, J., Siesjo, B. K. & Symon, L. Thresholds in cerebral ischemia\u2014the ischemic penumbra. Stroke 12, 723\u2013725 (1981).","journal-title":"Stroke"},{"key":"118_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581\u20131587 (1995).","journal-title":"N. Engl. J. Med."},{"key":"118_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/bmj.314.7088.1151","volume":"314","author":"Stroke Unit Trialists\u2019 Collaboration","year":"1997","unstructured":"Stroke Unit Trialists\u2019 Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 314, 1151\u20131159 (1997). A key study demonstrating the benefits of care in a stroke unit for all stroke subtypes and subgroups.","journal-title":"BMJ"},{"key":"118_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384, 1929\u20131935 (2014). A meta-analysis of individual patient data from intravenous thrombolysis trials that emphasizes the important influence of time to treatment on patient outcomes.","journal-title":"Lancet"},{"key":"118_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","volume":"379","author":"G Thomalla","year":"2018","unstructured":"Thomalla, G. et al. MRI-guided thrombolysis for stroke with unknown time of onset. N. Engl. J. Med. 379, 611\u2013622 (2018).","journal-title":"N. Engl. J. Med."},{"key":"118_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1747-4949.2011.00730.x","volume":"7","author":"H Ma","year":"2012","unstructured":"Ma, H. et al. A multicentre, randomized, double blinded, placebo controlled phase 3 study to investigate extending the time for thrombolysis in emergency neurological deficits (EXTEND). Int. J. Stroke 7, 74\u201380 (2012).","journal-title":"Int. J. Stroke"},{"key":"118_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","volume":"394","author":"BCV Campbell","year":"2019","unstructured":"Campbell, B. C. V. et al. Extending thrombolysis to 4.5-9\u2009hours and wake-up stroke using perfusion imaging: a meta-analysis of individual patient data from EXTEND, ECASS4-EXTEND and EPITHET. Lancet 394, 139\u2013147 (2019). A meta-analysis of individual patient data from randomized controlled trials showing that extending thrombolysis to >4.5\u2009h after onset is possible using brain perfusion imaging.","journal-title":"Lancet"},{"key":"118_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723\u20131731 (2016). A meta-analysis of individual patient data from endovascular thrombectomy trials showing the robust benefits of therapy across the subgroups of\u00a0age, clinical severity and occlusion location.","journal-title":"Lancet"},{"key":"118_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","volume":"378","author":"GW Albers","year":"2018","unstructured":"Albers, G. W. et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N. Engl. J. Med. 378, 708\u2013718 (2018).","journal-title":"N. Engl. J. Med."},{"key":"118_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira, R. G. et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N. Engl. J. Med. 378, 11\u201321 (2018). Together with reference 11, this study provides evidence that extending thrombectomy to >6\u2009h after onset is possible using CT perfusion or MRI diffusion\/perfusion imaging.","journal-title":"N. Engl. J. Med."},{"key":"118_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver, J. L. et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316, 1279\u20131288 (2016). A meta-analysis of individual patient data indicating the strong effect of time to treatment on patient outcome in endovascular thrombectomy trials.","journal-title":"JAMA"},{"key":"118_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"Global Burden of Disease Stroke Collaborators","year":"2019","unstructured":"Global Burden of Disease Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 439\u2013458 (2019).","journal-title":"Lancet Neurol."},{"key":"118_CR15","unstructured":"World Stroke Organization. WSO global stroke fact sheet. WSO https:\/\/www.world-stroke.org\/images\/WSO_Global_Stroke_Fact_Sheet_final.pdf (2019)."},{"key":"118_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"Global Burden of Disease Causes of Death Collaborators","year":"2018","unstructured":"Global Burden of Disease Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017. Lancet 392, 1736\u20131788 (2018).","journal-title":"Lancet"},{"key":"118_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000441085","volume":"45","author":"VL Feigin","year":"2015","unstructured":"Feigin, V. L. et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 45, 161\u2013176 (2015).","journal-title":"Neuroepidemiology"},{"key":"118_CR18","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","volume":"1","author":"RV Krishnamurthi","year":"2013","unstructured":"Krishnamurthi, R. V. et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the global burden of disease study 2010. Lancet Glob. Health 1, e259\u2013e281 (2013).","journal-title":"Lancet Glob. Health"},{"key":"118_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000441098","volume":"45","author":"RV Krishnamurthi","year":"2015","unstructured":"Krishnamurthi, R. V. et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: data from the global burden of disease 2013 study. Neuroepidemiology 45, 190\u2013202 (2015).","journal-title":"Neuroepidemiology"},{"key":"118_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","volume":"120","author":"VL Feigin","year":"2017","unstructured":"Feigin, V. L., Norrving, B. & Mensah, G. A. Global burden of stroke. Circ. Res. 120, 439\u2013448 (2017).","journal-title":"Circ. Res."},{"key":"118_CR21","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1161\/STROKEAHA.112.665760","volume":"43","author":"S Bevan","year":"2012","unstructured":"Bevan, S. et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genome-wide associations. Stroke 43, 3161\u20133167 (2012).","journal-title":"Stroke"},{"key":"118_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell, M. J. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376, 112\u2013123 (2010).","journal-title":"Lancet"},{"key":"118_CR23","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1161\/STROKEAHA.115.010954","volume":"46","author":"OY Bang","year":"2015","unstructured":"Bang, O. Y., Ovbiagele, B. & Kim, J. S. Nontraditional risk factors for ischemic stroke: an update. Stroke 46, 3571\u20133578 (2015).","journal-title":"Stroke"},{"key":"118_CR24","doi-asserted-by":"publisher","first-page":"h1295","DOI":"10.1136\/bmj.h1295","volume":"350","author":"AS Shah","year":"2015","unstructured":"Shah, A. S. et al. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ 350, h1295 (2015).","journal-title":"BMJ"},{"key":"118_CR25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.2214\/ajr.174.6.1741657","volume":"174","author":"AM Shaaban","year":"2000","unstructured":"Shaaban, A. M. & Duerinckx, A. J. Wall shear stress and early atherosclerosis: a review. AJR Am. J. Roentgenol. 174, 1657\u20131665 (2000).","journal-title":"AJR Am. J. Roentgenol."},{"key":"118_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1747493016647736","volume":"13","author":"JS Kim","year":"2018","unstructured":"Kim, J. S., Kim, Y. J., Ahn, S. H. & Kim, B. J. Location of cerebral atherosclerosis: why is there a difference between East and West? Int. J. Stroke 13, 35\u201346 (2018).","journal-title":"Int. J. Stroke"},{"key":"118_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/neurintsurg-2017-013489","volume":"10","author":"B Jia","year":"2018","unstructured":"Jia, B. et al. Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis. J. Neurointerv. Surg. 10, 746\u2013750 (2018).","journal-title":"J. Neurointerv. Surg."},{"key":"118_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(13)70195-9","volume":"12","author":"CA Holmstedt","year":"2013","unstructured":"Holmstedt, C. A., Turan, T. N. & Chimowitz, M. I. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 12, 1106\u20131114 (2013).","journal-title":"Lancet Neurol."},{"key":"118_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/STROKEAHA.116.016368","volume":"48","author":"Y Hao","year":"2017","unstructured":"Hao, Y. et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute\u00a0ischemic stroke. Stroke 48, 1203\u20131209 (2017).","journal-title":"Stroke"},{"key":"118_CR30","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1161\/STROKEAHA.110.599464","volume":"41","author":"HW Nah","year":"2010","unstructured":"Nah, H. W., Kang, D. W., Kwon, S. U. & Kim, J. S. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke 41, 2822\u20132827 (2010).","journal-title":"Stroke"},{"key":"118_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/ng.3154","volume":"47","author":"S Debette","year":"2015","unstructured":"Debette, S. et al. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat. Genet. 47, 78\u201383 (2015).","journal-title":"Nat. Genet."},{"key":"118_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(12)70135-7","volume":"11","author":"A Ducros","year":"2012","unstructured":"Ducros, A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 11, 906\u2013917 (2012).","journal-title":"Lancet Neurol."},{"key":"118_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004267","volume":"10","author":"MS Link","year":"2017","unstructured":"Link, M. S. et al. Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from\u00a0the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ. Arrhythm. Electrophysiol. 10, e004267 (2017).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"118_CR34","first-page":"195","volume":"14","author":"CA Morillo","year":"2017","unstructured":"Morillo, C. A., Banerjee, A., Perel, P., Wood, D. & Jouven, X. Atrial fibrillation: the current epidemic. J. Geriatr. Cardiol. 14, 195\u2013203 (2017).","journal-title":"J. Geriatr. Cardiol."},{"key":"118_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau, D. H., Nattel, S., Kalman, J. M. & Sanders, P. Modifiable risk factors and atrial fibrillation. Circulation 136, 583\u2013596 (2017).","journal-title":"Circulation"},{"key":"118_CR36","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893\u20132962 (2016).","journal-title":"Eur. Heart J."},{"key":"118_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","volume":"59","author":"PT Hagen","year":"1984","unstructured":"Hagen, P. T., Scholz, D. G. & Edwards, W. D. Incidence and size of patent foramen ovale during the first 10\u00a0decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc. 59, 17\u201320 (1984).","journal-title":"Mayo Clin. Proc."},{"key":"118_CR38","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas, J. L. et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N. Engl. J. Med. 377, 1011\u20131021 (2017).","journal-title":"N. Engl. J. Med."},{"key":"118_CR39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver, J. L. et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N. Engl. J. Med. 377, 1022\u20131032 (2017). A key randomized controlled trial demonstrating benefits of PFO closure in selected patients.","journal-title":"N. Engl. J. Med."},{"key":"118_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard, L. et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N. Engl. J. Med. 377, 1033\u20131042 (2017).","journal-title":"N. Engl. J. Med."},{"key":"118_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11940-013-0235-8","volume":"15","author":"AA Pruitt","year":"2013","unstructured":"Pruitt, A. A. Neurologic complications of infective endocarditis. Curr. Treat. Options Neurol. 15, 465\u2013476 (2013).","journal-title":"Curr. Treat. Options Neurol."},{"key":"118_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00043798-199504000-00004","volume":"2","author":"PT Vaitkus","year":"1995","unstructured":"Vaitkus, P. T. Left ventricular mural thrombus and the risk of embolic stroke after acute myocardial infarction. J. Cardiovasc. Risk 2, 103\u2013106 (1995).","journal-title":"J. Cardiovasc. Risk"},{"key":"118_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000103620","volume":"24","author":"A Grabowski","year":"2007","unstructured":"Grabowski, A., Kilian, J., Strank, C., Cieslinski, G. & Meyding-Lamade, U. Takotsubo cardiomyopathy \u2014 a rare cause of cardioembolic stroke. Cerebrovasc. Dis. 24, 146\u2013148 (2007).","journal-title":"Cerebrovasc. Dis."},{"key":"118_CR44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/17474086.2016.1208555","volume":"9","author":"A Arboix","year":"2016","unstructured":"Arboix, A., Jimenez, C., Massons, J., Parra, O. & Besses, C. Hematological disorders: a commonly unrecognized cause of acute stroke. Expert Rev. Hematol. 9, 891\u2013901 (2016).","journal-title":"Expert Rev. Hematol."},{"key":"118_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1474-4422(06)70469-0","volume":"5","author":"JA Switzer","year":"2006","unstructured":"Switzer, J. A., Hess, D. C., Nichols, F. T. & Adams, R. J. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 5, 501\u2013512 (2006).","journal-title":"Lancet Neurol."},{"key":"118_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/jcbfm.2010.10","volume":"30","author":"H Zhang","year":"2010","unstructured":"Zhang, H., Prabhakar, P., Sealock, R. & Faber, J. E. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J. Cereb. Blood Flow Metab. 30, 923\u2013934 (2010).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR47","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/jcbfm.2013.77","volume":"33","author":"BCV Campbell","year":"2013","unstructured":"Campbell, B. C. V. et al. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J. Cereb. Blood Flow Metab. 33, 1168\u20131172 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR48","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1161\/STROKEAHA.117.017673","volume":"48","author":"M Rocha","year":"2017","unstructured":"Rocha, M. & Jovin, T. G. Fast versus slow progressors of infarct growth in large vessel occlusion stroke: clinical and research implications. Stroke 48, 2621\u20132627 (2017).","journal-title":"Stroke"},{"key":"118_CR49","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/jcbfm.2010.66","volume":"30","author":"DW Howells","year":"2010","unstructured":"Howells, D. W. et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 1412\u20131431 (2010).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.20741","volume":"59","author":"VE O\u2019Collins","year":"2006","unstructured":"O\u2019Collins, V. E. et al. 1,026 experimental treatments in acute stroke. Ann. Neurol. 59, 467\u2013477 (2006).","journal-title":"Ann. Neurol."},{"key":"118_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1471-4159.1993.tb03553.x","volume":"61","author":"TP Obrenovitch","year":"1993","unstructured":"Obrenovitch, T. P. et al. Extracellular neuroactive amino acids in the rat striatum during ischaemia: comparison between penumbral conditions and ischaemia with sustained anoxic depolarisation. J.\u00a0Neurochem. 61, 178\u2013186 (1993).","journal-title":"J. Neurochem."},{"key":"118_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/307462a0","volume":"307","author":"L Nowak","year":"1984","unstructured":"Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. & Prochiantz, A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462\u2013465 (1984).","journal-title":"Nature"},{"key":"118_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu, Q. J. & Tymianski, M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol. Brain 11, 15 (2018).","journal-title":"Mol. Brain"},{"key":"118_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0165-6147(90)90254-6","volume":"11","author":"ML Mayer","year":"1990","unstructured":"Mayer, M. L. & Miller, R. J. Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons. Trends Pharmacol. Sci. 11, 254\u2013260 (1990).","journal-title":"Trends Pharmacol. Sci."},{"key":"118_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1750-3639.1999.tb00214.x","volume":"9","author":"S Love","year":"1999","unstructured":"Love, S. Oxidative stress in brain ischemia. Brain Pathol. 9, 119\u2013131 (1999).","journal-title":"Brain Pathol."},{"key":"118_CR56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.brainresbull.2019.04.023","volume":"149","author":"M Zuo","year":"2019","unstructured":"Zuo, M. et al. Wallerian degeneration in experimental focal cortical ischemia. Brain Res. Bull. 149, 194\u2013202 (2019).","journal-title":"Brain Res. Bull."},{"key":"118_CR57","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/STROKEAHA.115.011576","volume":"47","author":"A Bigourdan","year":"2016","unstructured":"Bigourdan, A. et al. Early fiber number ratio is a surrogate of corticospinal tract integrity and predicts motor recovery after stroke. Stroke 47, 1053\u20131059 (2016).","journal-title":"Stroke"},{"key":"118_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/jcbfm.1988.18","volume":"8","author":"E Ozyurt","year":"1988","unstructured":"Ozyurt, E., Graham, D. I., Woodruff, G. N. & McCulloch, J. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow Metab. 8, 138\u2013143 (1988).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.niox.2005.01.003","volume":"12","author":"M Willmot","year":"2005","unstructured":"Willmot, M., Gray, L., Gibson, C., Murphy, S. & Bath,\u00a0P. M. A systematic review of nitric oxide donors and l-arginine in experimental stroke: effects on infarct size and cerebral blood flow. Nitric Oxide 12, 141\u2013149 (2005).","journal-title":"Nitric Oxide"},{"key":"118_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/jcbfm.1994.119","volume":"14","author":"RC Crumrine","year":"1994","unstructured":"Crumrine, R. C., Thomas, A. L. & Morgan, P. F. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14, 887\u2013891 (1994).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR61","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1177\/0271678X16654495","volume":"37","author":"JA Hartings","year":"2017","unstructured":"Hartings, J. A. et al. The continuum of spreading depolarizations in acute cortical lesion development: examining Leao\u2019s legacy. J. Cereb. Blood Flow Metab. 37, 1571\u20131594 (2017).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR62","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ana.21390","volume":"63","author":"C Dohmen","year":"2008","unstructured":"Dohmen, C. et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann. Neurol. 63, 720\u2013728 (2008).","journal-title":"Ann. Neurol."},{"key":"118_CR63","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.4103\/1673-5374.194759","volume":"11","author":"PP Shen","year":"2016","unstructured":"Shen, P. P. et al. Cortical spreading depression-induced preconditioning in the brain. Neural Regen. Res. 11, 1857\u20131864 (2016).","journal-title":"Neural Regen. Res."},{"key":"118_CR64","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1023\/A:1010956711295","volume":"26","author":"VL Rao","year":"2001","unstructured":"Rao, V. L., Bowen, K. K. & Dempsey, R. J. Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem. Res. 26, 497\u2013502 (2001).","journal-title":"Neurochem. Res."},{"key":"118_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"118_CR66","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/glia.22657","volume":"62","author":"L Tarassishin","year":"2014","unstructured":"Tarassishin, L., Suh, H. S. & Lee, S. C. LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14. Glia 62, 999\u20131013 (2014).","journal-title":"Glia"},{"key":"118_CR67","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.nbd.2015.05.003","volume":"85","author":"GR Choudhury","year":"2016","unstructured":"Choudhury, G. R. & Ding, S. Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol. Dis. 85, 234\u2013244 (2016).","journal-title":"Neurobiol. Dis."},{"key":"118_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/01.WCB.0000053472.41007.F9","volume":"23","author":"D Dewar","year":"2003","unstructured":"Dewar, D., Underhill, S. M. & Goldberg, M. P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab. 23, 263\u2013274 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0006-8993(03)03317-1","volume":"989","author":"K Tanaka","year":"2003","unstructured":"Tanaka, K., Nogawa, S., Suzuki, S., Dembo, T. & Kosakai, A. Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area\u00a0in the rat brain. Brain Res. 989, 172\u2013179 (2003).","journal-title":"Brain Res."},{"key":"118_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","volume":"508","author":"CN Hall","year":"2014","unstructured":"Hall, C. N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55\u201360 (2014).","journal-title":"Nature"},{"key":"118_CR71","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.STR.0000126891.93919.4e","volume":"35","author":"C Wojcik","year":"2004","unstructured":"Wojcik, C. & Di Napoli, M. Ubiquitin-proteasome system and proteasome inhibition: new strategies in\u00a0stroke therapy. Stroke 35, 1506\u20131518 (2004).","journal-title":"Stroke"},{"key":"118_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neures.2017.09.002","volume":"131","author":"K Zhang","year":"2018","unstructured":"Zhang, K. et al. The Pyk2\/MCU pathway in the rat middle cerebral artery occlusion model of ischemic stroke. Neurosci. Res. 131, 52\u201362 (2018).","journal-title":"Neurosci. Res."},{"key":"118_CR73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/ijs.12434","volume":"10","author":"J Bai","year":"2015","unstructured":"Bai, J. & Lyden, P. D. Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. Int. J. Stroke 10, 143\u2013152 (2015).","journal-title":"Int. J. Stroke"},{"key":"118_CR74","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","volume":"8","author":"A Chamorro","year":"2012","unstructured":"Chamorro, A. et al. The immunology of acute stroke. Nat. Rev. Neurol. 8, 401\u2013410 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"118_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2018.07.003","volume":"323","author":"I Wimmer","year":"2018","unstructured":"Wimmer, I., Zrzavy, T. & Lassmann, H. Neuroinflammatory responses in experimental and human stroke lesions. J. Neuroimmunol. 323, 10\u201318 (2018).","journal-title":"J. Neuroimmunol."},{"key":"118_CR76","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/bpa.12583","volume":"28","author":"T Zrzavy","year":"2018","unstructured":"Zrzavy, T. et al. Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts. Brain Pathol. 28, 791\u2013805 (2018).","journal-title":"Brain Pathol."},{"key":"118_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).","journal-title":"F1000Prime Rep."},{"key":"118_CR78","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0271678X15606714","volume":"36","author":"S Maysami","year":"2016","unstructured":"Maysami, S. et al. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. J. Cereb. Blood Flow Metab. 36, 596\u2013605 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(16)30357-X","volume":"16","author":"J Elkins","year":"2017","unstructured":"Elkins, J. et al. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 16, 217\u2013226 (2017).","journal-title":"Lancet Neurol."},{"key":"118_CR80","doi-asserted-by":"publisher","first-page":"299ra121","DOI":"10.1126\/scitranslmed.aaa9853","volume":"7","author":"G Llovera","year":"2015","unstructured":"Llovera, G. et al. Results of a preclinical randomized controlled multicenter trial (pRCT): anti-CD49d treatment for acute brain ischemia. Sci. Transl Med. 7, 299ra121 (2015).","journal-title":"Sci. Transl Med."},{"key":"118_CR81","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000658-190209000-00001","volume":"36","author":"HI Cushing","year":"1902","unstructured":"Cushing, H. I. On the avoidance of shock in major amputations by cocainization of large nerve-trunks preliminary to their division, with observations on blood-pressure changes in surgical cases. Ann. Surg. 36, 321\u2013345 (1902).","journal-title":"Ann. Surg."},{"key":"118_CR82","unstructured":"Ko, N. U. in Aminoff\u2019s Neurology and General Medicine (ed. Aminoff, M. J.) 183\u2013198 (Academic Press, 2014)."},{"key":"118_CR83","first-page":"54","volume":"16","author":"W Shanahan","year":"1908","unstructured":"Shanahan, W. Acute pulmonary edema as a complication of epileptic seizures. NY Med. J. 16, 54\u201356 (1908).","journal-title":"NY Med. J."},{"key":"118_CR84","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1445-5994.1999.tb00789.x","volume":"29","author":"RM L\u2019E Orme","year":"1999","unstructured":"L\u2019E Orme, R. M., McGrath, N. M., Rankin, R. J. & Frith, R. W. Extracranial vertebral artery dissection presenting as neurogenic pulmonary oedema. Aust. NZ J. Med. 29, 824\u2013825 (1999).","journal-title":"Aust. NZ J. Med."},{"key":"118_CR85","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather, J. & Iadecola, C. Inflammation and stroke: an overview. Neurotherapeutics 13, 661\u2013670 (2016).","journal-title":"Neurotherapeutics"},{"key":"118_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072758","volume":"8","author":"WJ Zi","year":"2013","unstructured":"Zi, W. J. & Shuai, J. Cortisol as a prognostic marker of\u00a0short-term outcome in Chinese patients with acute\u00a0ischemic stroke. PLOS ONE 8, e72758 (2013).","journal-title":"PLOS ONE"},{"key":"118_CR87","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","volume":"26","author":"H Offner","year":"2006","unstructured":"Offner, H. et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654\u2013665 (2006).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR88","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCRESAHA.116.305207","volume":"116","author":"G Courties","year":"2015","unstructured":"Courties, G. et al. Ischemic stroke activates hematopoietic bone marrow stem cells. Circ. Res. 116, 407\u2013417 (2015).","journal-title":"Circ. Res."},{"key":"118_CR89","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.18632\/aging.100952","volume":"8","author":"J Crapser","year":"2016","unstructured":"Crapser, J. et al. Ischemic stroke induces gut permeability and enhances bacterial translocation leading to sepsis in aged mice. Aging 8, 1049\u20131063 (2016).","journal-title":"Aging"},{"key":"118_CR90","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1523\/JNEUROSCI.1114-16.2016","volume":"36","author":"V Singh","year":"2016","unstructured":"Singh, V. et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci. 36, 7428\u20137440 (2016).","journal-title":"J. Neurosci."},{"key":"118_CR91","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.114.006647","volume":"46","author":"S Wu","year":"2015","unstructured":"Wu, S., Mead, G., Macleod, M. & Chalder, T. Model of\u00a0understanding fatigue after stroke. Stroke 46, 893\u2013898 (2015).","journal-title":"Stroke"},{"key":"118_CR92","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1515\/revneuro-2018-0082","volume":"30","author":"A Desowska","year":"2019","unstructured":"Desowska, A. & Turner, D. L. Dynamics of brain connectivity after stroke. Rev. Neurosci. 30, 605\u2013623 (2019).","journal-title":"Rev. Neurosci."},{"key":"118_CR93","doi-asserted-by":"publisher","first-page":"13198","DOI":"10.1073\/pnas.0603512103","volume":"103","author":"K Jin","year":"2006","unstructured":"Jin, K. et al. Evidence for stroke-induced neurogenesis in the human brain. Proc. Natl Acad. Sci. USA 103, 13198\u201313202 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"118_CR94","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1747-4949.2012.00797.x","volume":"7","author":"JS Lees","year":"2012","unstructured":"Lees, J. S. et al. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int. J. Stroke 7, 582\u2013588 (2012).","journal-title":"Int. J. Stroke"},{"key":"118_CR95","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1177\/0963689718806846","volume":"27","author":"H Zheng","year":"2018","unstructured":"Zheng, H. et al. Mesenchymal stem cell therapy in stroke: a systematic review of literature in pre-clinical and clinical research. Cell Transpl. 27, 1723\u20131730 (2018).","journal-title":"Cell Transpl."},{"key":"118_CR96","first-page":"4826407","volume":"2018","author":"H Huang","year":"2018","unstructured":"Huang, H. et al. Intraparenchymal neural stem\/progenitor cell transplantation for ischemic stroke animals: a meta-analysis and systematic review. Stem Cells Int. 2018, 4826407 (2018).","journal-title":"Stem Cells Int."},{"key":"118_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1747-4949.2012.00859.x","volume":"10","author":"S Bal","year":"2015","unstructured":"Bal, S. et al. Time dependence of reliability of noncontrast computed tomography in comparison to computed tomography angiography source image in acute ischemic stroke. Int. J. Stroke 10, 55\u201360 (2015).","journal-title":"Int. J. Stroke"},{"key":"118_CR98","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1474-4422(18)30242-4","volume":"17","author":"LS Roman","year":"2018","unstructured":"Roman, L. S. et al. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol. 17, 895\u2013904 (2018).","journal-title":"Lancet Neurol."},{"key":"118_CR99","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ana.20595","volume":"58","author":"N Hjort","year":"2005","unstructured":"Hjort, N. et al. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann. Neurol. 58, 462\u2013465 (2005).","journal-title":"Ann. Neurol."},{"key":"118_CR100","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/jcbfm.2011.102","volume":"32","author":"BCV Campbell","year":"2012","unstructured":"Campbell, B. C. V. et al. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J. Cereb. Blood Flow Metab. 32, 50\u201356 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"118_CR101","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","volume":"6","author":"JM Simard","year":"2007","unstructured":"Simard, J. M., Kent, T. A., Chen, M., Tarasov, K. V. & Gerzanich, V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 6, 258\u2013268 (2007).","journal-title":"Lancet Neurol."},{"key":"118_CR102","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1377\/hlthaff.2016.1231","volume":"36","author":"MA Colchero","year":"2017","unstructured":"Colchero, M. A., Rivera-Dommarco, J., Popkin, B. M. & Ng, S. W. In Mexico, evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax. Health Aff. 36, 564\u2013571 (2017).","journal-title":"Health Aff."},{"key":"118_CR103","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.jacc.2014.08.021","volume":"64","author":"JM Castellano","year":"2014","unstructured":"Castellano, J. M. et al. A polypill strategy to improve adherence: results from the FOCUS project. J. Am. Coll. Cardiol. 64, 2071\u20132082 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"118_CR104","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil, J. J. et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N. Engl. J. Med. 379, 1509\u20131518 (2018). A key randomized controlled trial demonstrating a lack of benefit of aspirin in patients without established cardiovascular disease.","journal-title":"N. Engl. J. Med."},{"key":"118_CR105","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman, B., Potpara, T. S. & Lip, G. Y. Stroke prevention in atrial fibrillation. Lancet 388, 806\u2013817 (2016).","journal-title":"Lancet"},{"key":"118_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ijs.12371","volume":"9","author":"P Lindsay","year":"2014","unstructured":"Lindsay, P., Furie, K. L., Davis, S. M., Donnan, G. A. & Norrving, B. World Stroke Organization global stroke services guidelines and action plan. Int. J. Stroke 9, 4\u201313 (2014).","journal-title":"Int. J. Stroke"},{"key":"118_CR107","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","volume":"349","author":"CAST (Chinese Acute Stroke Trial) Collaborative Group","year":"1997","unstructured":"CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of\u00a0early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349, 1641\u20131649 (1997).","journal-title":"Lancet"},{"key":"118_CR108","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","volume":"349","author":"International Stroke Trial Collaborative Group","year":"1997","unstructured":"International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of\u00a0aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349, 1569\u20131581 (1997).","journal-title":"Lancet"},{"key":"118_CR109","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL Sacco","year":"2008","unstructured":"Sacco, R. L. et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N. Engl. J. Med. 359, 1238\u20131251 (2008).","journal-title":"N. Engl. J. Med."},{"key":"118_CR110","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston, S. C. et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N. Engl. J. Med. 379, 215\u2013225 (2018). A key randomized controlled trial demonstrating the benefits of aspirin and clopidogrel for ~3 weeks in patients with minor stroke and TIA.","journal-title":"N. Engl. J. Med."},{"key":"118_CR111","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","volume":"140","author":"SC Johnston","year":"2019","unstructured":"Johnston, S. C. et al. Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke. Circulation 140, 658\u2013664 (2019).","journal-title":"Circulation"},{"key":"118_CR112","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke, W. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274, 1017\u20131025 (1995).","journal-title":"JAMA"},{"key":"118_CR113","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke, W. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352, 1245\u20131251 (1998).","journal-title":"Lancet"},{"key":"118_CR114","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/hs0202.102599","volume":"33","author":"GW Albers","year":"2002","unstructured":"Albers, G. W., Clark, W. M., Madden, K. P. & Hamilton,\u00a0S. A. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke 33, 493\u2013495 (2002).","journal-title":"Stroke"},{"key":"118_CR115","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","volume":"282","author":"WM Clark","year":"1999","unstructured":"Clark, W. M. et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5\u2009hours after symptom onset. The Atlantis study: a\u00a0randomized controlled trial. alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 282, 2019\u20132026 (1999).","journal-title":"JAMA"},{"key":"118_CR116","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","volume":"379","author":"P Sandercock","year":"2012","unstructured":"Sandercock, P. et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet 379, 2352\u20132363 (2012).","journal-title":"Lancet"},{"key":"118_CR117","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","volume":"375","author":"KR Lees","year":"2010","unstructured":"Lees, K. R. et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375, 1695\u20131703 (2010).","journal-title":"Lancet"},{"key":"118_CR118","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1161\/STROKEAHA.114.006222","volume":"45","author":"M Muchada","year":"2014","unstructured":"Muchada, M. et al. Impact of time to treatment on tissue-type plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 45, 2734\u20132738 (2014).","journal-title":"Stroke"},{"key":"118_CR119","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","volume":"16","author":"N Logallo","year":"2017","unstructured":"Logallo, N. et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol. 16, 781\u2013788 (2017).","journal-title":"Lancet Neurol."},{"key":"118_CR120","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/STROKEAHA.116.015164","volume":"48","author":"G Mair","year":"2017","unstructured":"Mair, G. et al. Arterial obstruction on computed tomographic or magnetic resonance angiography and response to intravenous thrombolytics in ischemic stroke. Stroke 48, 353\u2013360 (2017).","journal-title":"Stroke"},{"key":"118_CR121","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamaneurol.2019.0351","volume":"76","author":"E Barow","year":"2019","unstructured":"Barow, E. et al. Functional outcome of intravenous thrombolysis in patients with lacunar infarcts in the wake-up trial. JAMA Neurol. 76, 641\u2013649 (2019).","journal-title":"JAMA Neurol."},{"key":"118_CR122","unstructured":"Stroke Foundation. National stroke audit acute services. InformMe https:\/\/informme.org.au\/stroke-data\/Acute-audits (2017)."},{"key":"118_CR123","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","volume":"41","author":"P Tanswell","year":"2002","unstructured":"Tanswell, P., Modi, N., Combs, D. & Danays, T. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin. Pharmacokinet. 41, 1229\u20131245 (2002).","journal-title":"Clin. Pharmacokinet."},{"key":"118_CR124","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"PT O\u2019Gara","year":"2013","unstructured":"O\u2019Gara, P. T. et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a\u00a0report of the American College of Cardiology Foundation\/American Heart Association task force on\u00a0practice guidelines. Circulation 127, e362\u2013e425 (2013).","journal-title":"Circulation"},{"key":"118_CR125","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/1747493018790024","volume":"13","author":"SB Coutts","year":"2018","unstructured":"Coutts, S. B., Berge, E., Campbell, B. C., Muir, K. W. & Parsons, M. W. Tenecteplase for the treatment of acute ischemic stroke: a review of completed and ongoing randomized controlled trials. Int. J. Stroke 13, 885\u2013892 (2018).","journal-title":"Int. J. Stroke"},{"key":"118_CR126","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","volume":"366","author":"MW Parsons","year":"2012","unstructured":"Parsons, M. W. et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N. Engl. J. Med. 366, 1099\u20131107 (2012).","journal-title":"N. Engl. J. Med."},{"key":"118_CR127","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","volume":"378","author":"BCV Campbell","year":"2018","unstructured":"Campbell, B. C. V. et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N. Engl. J. Med. 378, 1573\u20131582 (2018).","journal-title":"N. Engl. J. Med."},{"key":"118_CR128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.0000000000004062","volume":"89","author":"A Bivard","year":"2017","unstructured":"Bivard, A. et al. Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology 89, 62\u201367 (2017).","journal-title":"Neurology"},{"key":"118_CR129","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers, W. J. et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a\u00a0guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 49, e46\u2013e110 (2018).","journal-title":"Stroke"},{"key":"118_CR130","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","volume":"15","author":"WN Whiteley","year":"2016","unstructured":"Whiteley, W. N. et al. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol. 15, 925\u2013933 (2016).","journal-title":"Lancet Neurol."},{"key":"118_CR131","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1161\/STROKEAHA.116.013165","volume":"47","author":"NH Chia","year":"2016","unstructured":"Chia, N. H., Leyden, J. M., Newbury, J., Jannes, J. & Kleinig, T. J. Determining the number of ischemic strokes potentially eligible for endovascular thrombectomy: a population-based study. Stroke 47, 1377\u20131380 (2016).","journal-title":"Stroke"},{"key":"118_CR132","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1474-4422(17)30407-6","volume":"17","author":"BCV Campbell","year":"2018","unstructured":"Campbell, B. C. V. et al. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data. Lancet Neurol. 17, 47\u201353 (2018).","journal-title":"Lancet Neurol."},{"key":"118_CR133","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1214300","volume":"368","author":"JP Broderick","year":"2013","unstructured":"Broderick, J. P. et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368, 893\u2013903 (2013).","journal-title":"N. Engl. J. Med."},{"key":"118_CR134","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2017.9644","volume":"318","author":"B Lapergue","year":"2017","unstructured":"Lapergue, B. et al. Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA 318, 443\u2013452 (2017).","journal-title":"JAMA"},{"key":"118_CR135","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/neurintsurg-2017-013722","volume":"10","author":"AS Turk","year":"2018","unstructured":"Turk, A. S., Siddiqui, A. H. & Mocco, J. A comparison of direct aspiration versus stent retriever as a first approach (\u2018COMPASS\u2019): protocol. J. Neurointerv. Surg. 10, 953\u2013957 (2018).","journal-title":"J. Neurointerv. Surg."},{"key":"118_CR136","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/1747493017701153","volume":"12","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Acute basilar artery occlusion: endovascular interventions versus standard medical treatment (best) trial-design and protocol for a randomized, controlled, multicenter study. Int. J. Stroke 12, 779\u2013785 (2017).","journal-title":"Int. J. Stroke"},{"key":"118_CR137","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1161\/STROKEAHA.117.017235","volume":"48","author":"FC Ng","year":"2017","unstructured":"Ng, F. C. et al. Deconstruction of interhospital transfer workflow in large vessel occlusion: real-world data in the thrombectomy era. Stroke 48, 1976\u20131979 (2017).","journal-title":"Stroke"},{"key":"118_CR138","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.2018.12498","volume":"320","author":"BK Menon","year":"2018","unstructured":"Menon, B. K. et al. Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA 320, 1017\u20131026 (2018).","journal-title":"JAMA"},{"key":"118_CR139","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/STROKEAHA.113.003071","volume":"45","author":"N Perez de la Ossa","year":"2014","unstructured":"Perez de la Ossa, N. et al. Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale. Stroke 45, 87\u201391 (2014).","journal-title":"Stroke"},{"key":"118_CR140","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/312703002806","volume":"8","author":"JN Llanes","year":"2004","unstructured":"Llanes, J. N. et al. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp. Emerg. Care 8, 46\u201350 (2004).","journal-title":"Prehosp. Emerg. Care"},{"key":"118_CR141","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1161\/STROKEAHA.117.019307","volume":"49","author":"H Zhao","year":"2018","unstructured":"Zhao, H. et al. Ambulance clinical triage for acute stroke treatment: paramedic triage algorithm for large vessel occlusion. Stroke 49, 945\u2013951 (2018).","journal-title":"Stroke"},{"key":"118_CR142","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jama.2014.2850","volume":"311","author":"M Ebinger","year":"2014","unstructured":"Ebinger, M. et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 311, 1622\u20131631 (2014).","journal-title":"JAMA"},{"key":"118_CR143","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2165\/00023210-200822010-00006","volume":"22","author":"L Ehlers","year":"2008","unstructured":"Ehlers, L., Muskens, W. M., Jensen, L. G., Kjolby, M. & Andersen, G. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness. CNS Drugs 22, 73\u201381 (2008).","journal-title":"CNS Drugs"},{"key":"118_CR144","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/STROKEAHA.116.014735","volume":"48","author":"TI Shireman","year":"2017","unstructured":"Shireman, T. I. et al. Cost-effectiveness of solitaire stent retriever thrombectomy for acute ischemic stroke: results from the swift-prime trial (solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke). Stroke 48, 379\u2013387 (2017).","journal-title":"Stroke"},{"key":"118_CR145","unstructured":"World Health Organization. World Health Organization model list of essential medicines, 21st list https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1 (2019)."},{"key":"118_CR146","unstructured":"World Bank. World Bank national accounts data https:\/\/data.worldbank.org\/country\/india (2017)."},{"key":"118_CR147","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa1515510","volume":"374","author":"CS Anderson","year":"2016","unstructured":"Anderson, C. S. et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N. Engl. J. Med. 374, 2313\u20132323 (2016).","journal-title":"N. Engl. J. Med."},{"key":"118_CR148","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1474-4422(07)70036-4","volume":"6","author":"K Vahedi","year":"2007","unstructured":"Vahedi, K. et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 6, 215\u2013222 (2007).","journal-title":"Lancet Neurol."},{"key":"118_CR149","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","volume":"15","author":"KN Sheth","year":"2016","unstructured":"Sheth, K. N. et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 15, 1160\u20131169 (2016).","journal-title":"Lancet Neurol."},{"key":"118_CR150","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(07)60633-3","volume":"369","author":"DG Sherman","year":"2007","unstructured":"Sherman, D. G. et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL study): an open-label randomised comparison. Lancet 369, 1347\u20131355 (2007).","journal-title":"Lancet"},{"key":"118_CR151","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(13)61050-8","volume":"382","author":"CLOTS Trial Collaboration","year":"2013","unstructured":"CLOTS Trial Collaboration. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet 382, 516\u2013524 (2013).","journal-title":"Lancet"},{"key":"118_CR152","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(11)61485-2","volume":"378","author":"S Middleton","year":"2011","unstructured":"Middleton, S. et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a\u00a0cluster randomised controlled trial. Lancet 378, 1699\u20131706 (2011).","journal-title":"Lancet"},{"key":"118_CR153","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(19)30038-8","volume":"393","author":"CS Anderson","year":"2019","unstructured":"Anderson, C. S. et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet 393, 877\u2013888 (2019).","journal-title":"Lancet"},{"key":"118_CR154","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(19)30194-1","volume":"393","author":"RIGHT Investigators","year":"2019","unstructured":"RIGHT Investigators. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet 393, 1009\u20131020 (2019).","journal-title":"Lancet"},{"key":"118_CR155","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","volume":"377","author":"EC Sandset","year":"2011","unstructured":"Sandset, E. C. et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377, 741\u2013750 (2011).","journal-title":"Lancet"},{"key":"118_CR156","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","volume":"24","author":"H Arima","year":"2006","unstructured":"Arima, H. et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J. Hypertens. 24, 1201\u20131208 (2006).","journal-title":"J. Hypertens."},{"key":"118_CR157","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"SPRINT Research Group","year":"2015","unstructured":"SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"key":"118_CR158","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348, 1329\u20131339 (1996).","journal-title":"Lancet"},{"key":"118_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N. Engl. J. Med. 369, 11\u201319 (2013).","journal-title":"N. Engl. J. Med."},{"key":"118_CR160","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/jnnp-2018-318658","volume":"90","author":"D Giannandrea","year":"2019","unstructured":"Giannandrea, D. et al. Intravenous thrombolysis in stroke after dabigatran reversal with idarucizumab: case series and systematic review. J. Neurol. Neurosurg. Psychiatry 90, 619\u2013623 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"118_CR161","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1747493018790081","volume":"14","author":"H Zhao","year":"2019","unstructured":"Zhao, H. et al. Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit. Int.\u00a0J. Stroke 14, 265\u2013269 (2019).","journal-title":"Int. J. Stroke"},{"key":"118_CR162","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/europace\/eux313","volume":"20","author":"M Nishimura","year":"2017","unstructured":"Nishimura, M., Sab, S., Reeves, R. R. & Hsu, J. C. Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review. Europace 20, 1412\u20131419 (2017).","journal-title":"Europace"},{"key":"118_CR163","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco, P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355, 549\u2013559 (2006).","journal-title":"N. Engl. J. Med."},{"key":"118_CR164","first-page":"787","volume":"377","author":"MS Sabatine","year":"2017","unstructured":"Sabatine, M. S., Giugliano, R. P. & Pedersen, T. R. Evolocumab in patients with cardiovascular disease. N. Engl. J. Med. 377, 787\u2013788 (2017).","journal-title":"N. Engl. J. Med."},{"key":"118_CR165","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0140-6736(10)61197-X","volume":"376","author":"A Halliday","year":"2010","unstructured":"Halliday, A. et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 376, 1074\u20131084 (2010).","journal-title":"Lancet"},{"key":"118_CR166","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(15)01309-4","volume":"387","author":"G Howard","year":"2016","unstructured":"Howard, G. et al. Association between age and risk of\u00a0stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet 387, 1305\u20131311 (2016).","journal-title":"Lancet"},{"key":"118_CR167","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz, M. I. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 365, 993\u20131003 (2011).","journal-title":"N. Engl. J. Med."},{"key":"118_CR168","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"P Lechat","year":"1988","unstructured":"Lechat, P. et al. Prevalence of patent foramen ovale in\u00a0patients with stroke. N. Engl. J. Med. 318, 1148\u20131152 (1988).","journal-title":"N. Engl. J. Med."},{"key":"118_CR169","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0140-6736(15)60690-0","volume":"386","author":"AVERT Trial Collaboration Group","year":"2015","unstructured":"AVERT Trial Collaboration Group. Efficacy and safety of\u00a0very early mobilisation within 24\u2009h of stroke onset (AVERT): a randomised controlled trial. Lancet 386, 46\u201355 (2015).","journal-title":"Lancet"},{"key":"118_CR170","unstructured":"Stroke Foundation. Clinical guidelines for stroke management 2017. InformMe https:\/\/informme.org.au\/Guidelines (2017)."},{"key":"118_CR171","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0140-6736(17)31447-2","volume":"390","author":"ATTEND Collaborative Group","year":"2017","unstructured":"ATTEND Collaborative Group. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial. Lancet 390, 588\u2013599 (2017).","journal-title":"Lancet"},{"key":"118_CR172","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1161\/STROKEAHA.114.008547","volume":"46","author":"N Chaisinanunkul","year":"2015","unstructured":"Chaisinanunkul, N. et al. Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin scale. Stroke 46, 2238\u20132243 (2015).","journal-title":"Stroke"},{"key":"118_CR173","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000441194","volume":"40","author":"A Ragoschke-Schumm","year":"2015","unstructured":"Ragoschke-Schumm, A. et al. Retrospective consent to\u00a0hemicraniectomy after malignant stroke among the\u00a0elderly, despite impaired functional outcome. Cerebrovasc. Dis. 40, 286\u2013292 (2015).","journal-title":"Cerebrovasc. Dis."},{"key":"118_CR174","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019919","volume":"8","author":"KH Lam","year":"2018","unstructured":"Lam, K. H. & Kwa, V. I. H. Validity of the PROMIS-10 Global Health assessed by telephone and on paper in\u00a0minor stroke and transient ischaemic attack in the Netherlands. BMJ Open 8, e019919 (2018).","journal-title":"BMJ Open"},{"key":"118_CR175","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","volume":"78","author":"D Cella","year":"2012","unstructured":"Cella, D. et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in\u00a0neurology. Neurology 78, 1860\u20131867 (2012).","journal-title":"Neurology"},{"key":"118_CR176","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11136-014-0834-1","volume":"24","author":"D Golicki","year":"2015","unstructured":"Golicki, D. et al. Validity of EQ-5D-5L in stroke. Qual. Life Res. 24, 845\u2013850 (2015).","journal-title":"Qual. Life Res."},{"key":"118_CR177","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ana.24953","volume":"81","author":"MG Lansberg","year":"2017","unstructured":"Lansberg, M. G. et al. Computed tomographic perfusion to predict response to recanalization in ischemic stroke. Ann. Neurol. 81, 849\u2013856 (2017).","journal-title":"Ann. Neurol."},{"key":"118_CR178","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(12)70203-X","volume":"11","author":"MG Lansberg","year":"2012","unstructured":"Lansberg, M. G. et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a\u00a0prospective cohort study. Lancet Neurol. 11, 860\u2013867 (2012).","journal-title":"Lancet Neurol."},{"key":"118_CR179","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/neurintsurg-2018-014127","volume":"11","author":"DS Liebeskind","year":"2018","unstructured":"Liebeskind, D. S. et al. eTICI reperfusion: defining success in endovascular stroke therapy. J. Neurointerv. Surg. 11, 433\u2013438 (2018).","journal-title":"J. Neurointerv. Surg."},{"key":"118_CR180","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/brain\/awp155","volume":"132","author":"F Miteff","year":"2009","unstructured":"Miteff, F. et al. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 132, 2231\u20132238 (2009).","journal-title":"Brain"},{"key":"118_CR181","doi-asserted-by":"crossref","first-page":"A187","DOI":"10.1161\/str.46.suppl_1.187","volume":"46","author":"C Bladin","year":"2015","unstructured":"Bladin, C. et al. Magnetically-enhanced diffusion (MED\u2122) of intravenous tPA in acute ischemic stroke: a\u00a0pilot safety and feasibility trial. Stroke 46, A187 (2015).","journal-title":"Stroke"},{"key":"118_CR182","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","volume":"123","author":"K Martinod","year":"2014","unstructured":"Martinod, K. & Wagner, D. D. Thrombosis: tangled up in NETs. Blood 123, 2768\u20132776 (2014).","journal-title":"Blood"},{"key":"118_CR183","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature10841","volume":"483","author":"DJ Cook","year":"2012","unstructured":"Cook, D. J., Teves, L. & Tymianski, M. Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 483, 213\u2013217 (2012).","journal-title":"Nature"},{"key":"118_CR184","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1474-4422(12)70225-9","volume":"11","author":"MD Hill","year":"2012","unstructured":"Hill, M. D. et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 11, 942\u2013950 (2012).","journal-title":"Lancet Neurol."},{"key":"118_CR185","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/ijs.12294","volume":"9","author":"HB van der Worp","year":"2014","unstructured":"van der Worp, H. B. et al. EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int. J. Stroke 9, 642\u2013645 (2014).","journal-title":"Int. J. Stroke"},{"key":"118_CR186","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/STROKEAHA.110.609933","volume":"42","author":"A Shuaib","year":"2011","unstructured":"Shuaib, A. et al. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke 42, 1680\u20131690 (2011).","journal-title":"Stroke"},{"key":"118_CR187","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1056\/NEJMoa1615715","volume":"376","author":"CS Anderson","year":"2017","unstructured":"Anderson, C. S. et al. Cluster-randomized, crossover trial of head positioning in acute stroke. N. Engl. J. Med. 376, 2437\u20132447 (2017).","journal-title":"N. Engl. J. Med."},{"key":"118_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039636","volume":"7","author":"H Levi","year":"2012","unstructured":"Levi, H. et al. Stimulation of the sphenopalatine ganglion induces reperfusion and blood-brain barrier protection in the photothrombotic stroke model. PLOS\u00a0ONE 7, e39636 (2012).","journal-title":"PLOS ONE"},{"key":"118_CR189","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(19)31192-4","volume":"394","author":"NM Bornstein","year":"2019","unstructured":"Bornstein, N. M. et al. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial. Lancet\u00a0394, 219\u2013229 (2019).","journal-title":"Lancet"},{"key":"118_CR190","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1212\/WNL.0b013e31825d6011","volume":"79","author":"A Meretoja","year":"2012","unstructured":"Meretoja, A. et al. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 79, 306\u2013313 (2012).","journal-title":"Neurology"},{"key":"118_CR191","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1212\/WNL.0b013e3182a4a4d2","volume":"81","author":"A Meretoja","year":"2013","unstructured":"Meretoja, A. et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology 81, 1071\u20131076 (2013).","journal-title":"Neurology"},{"key":"118_CR192","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S1474-4422(16)30073-4","volume":"15","author":"VL Feigin","year":"2016","unstructured":"Feigin, V. L. et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a\u00a0systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 15, 913\u2013924 (2016).","journal-title":"Lancet Neurol."},{"key":"118_CR193","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","volume":"6","author":"K Strong","year":"2007","unstructured":"Strong, K., Mathers, C. & Bonita, R. Preventing stroke: saving lives around the world. Lancet Neurol. 6, 182\u2013187 (2007).","journal-title":"Lancet Neurol."},{"key":"118_CR194","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(19)31055-4","volume":"394","author":"H Rodgers","year":"2019","unstructured":"Rodgers, H. et al. Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial. Lancet 394, 51\u201362 (2019).","journal-title":"Lancet"},{"key":"118_CR195","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","volume":"10","author":"F Chollet","year":"2011","unstructured":"Chollet, F. et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 10, 123\u2013130 (2011).","journal-title":"Lancet Neurol."},{"key":"118_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.5.JNS173147","volume":"1","author":"GK Steinberg","year":"2018","unstructured":"Steinberg, G. K. et al. Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1\/2a study. J. Neurosurg. 1, 1\u201311 (2018).","journal-title":"J. Neurosurg."},{"key":"118_CR197","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF02283018","volume":"7","author":"M Savoiardo","year":"1986","unstructured":"Savoiardo, M. The vascular territories of the carotid and vertebrobasilar systems. Diagrams based on CT studies of infarcts. Ital. J. Neurol. Sci. 7, 405\u2013409 (1986).","journal-title":"Ital. J. Neurol. Sci."},{"key":"118_CR198","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuron.2015.05.041","volume":"87","author":"PM George","year":"2015","unstructured":"George, P. M. & Steinberg, G. K. Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 87, 297\u2013309 (2015).","journal-title":"Neuron"}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0118-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:15:16Z","timestamp":1671232516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-019-0118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1038\/s41572-019-0118-8","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"21 August 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M.D. reports personal fees for advisory board membership and lectures for Boehringer Ingelheim and Medtronic. G.A.D. reports personal fees from Allergan, Amgen, Bayer, Boehringer Ingelheim, Pfizer and Servier. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}